Suppr超能文献

睡眠障碍的有效管理是否能降低抑郁症状和抑郁风险?

Does effective management of sleep disorders reduce depressive symptoms and the risk of depression?

机构信息

Department of Psychiatry and Psychotherapy, Freiburg University Medical Center, Freiburg, Germany.

出版信息

Drugs. 2009;69 Suppl 2:43-64. doi: 10.2165/11531130-000000000-00000.

Abstract

The link between co-morbid insomnia and depression has been demonstrated in numerous groups. Insomnia has been associated with: (1) an increased risk of developing subsequent depression; (2) an increased duration of established depression; and (3) relapse following treatment for depression. In addition, specific insomnia symptoms, such as nocturnal awakening with difficulty resuming sleep, are more strongly associated with depression than classic symptoms of insomnia. Participants of a workshop, held at the 6th annual meeting of The International Sleep Disorders Forum: The Art of Good Sleep in 2008, evaluated whether the effective management of sleep disorders could reduce both concurrent depressive symptoms and the risk of developing subsequent depression. Following the workshop, a targeted literature review was conducted. Initial evidence demonstrated that in patients with insomnia and co-morbid depression either pharmacological treatment of insomnia or psychological treatment in the form of cognitive behavioural therapy for insomnia improved both insomnia and depressive symptoms. Although these appeared to be promising treatment strategies, however, of the 27 identified treatment studies, only one large well-designed randomized controlled trial comparing the efficacy of eszopiclone plus fluoxetine with placebo plus fluoxetine demonstrated unequivocal evidence that improvements in insomnia symptoms conferred additive benefits on depressive outcomes. In addition, it was unclear whether any differences exist in efficacy between sedating versus non-sedating pharmacotherapies for insomnia in this patient group. Further studies of sufficient sample size and duration are needed to evaluate combinations of pharmacological (either sedating or non-sedating) and psychological interventions in co-morbid insomnia and depression. This article reviews the level of evidence, recommendations and areas of particular interest for further study and discussion arising from this workshop.

摘要

众多研究表明,共病性失眠与抑郁之间存在关联。失眠与以下因素相关:(1) 发展为后续抑郁的风险增加;(2) 既定抑郁的持续时间延长;以及(3) 抑郁治疗后的复发。此外,特定的失眠症状,如夜间醒来后难以再次入睡,与抑郁的相关性强于典型的失眠症状。在 2008 年第六届国际睡眠障碍论坛年度会议“良好睡眠的艺术”的一个研讨会上,与会者评估了睡眠障碍的有效管理是否可以降低同时存在的抑郁症状和发展为后续抑郁的风险。在研讨会之后,进行了一项针对性的文献回顾。初步证据表明,对于同时患有失眠和共病性抑郁的患者,失眠的药物治疗或失眠的认知行为疗法等心理治疗形式都可以改善失眠和抑郁症状。尽管这些似乎是有前途的治疗策略,但在 27 项确定的治疗研究中,只有一项大型精心设计的随机对照试验比较了艾司佐匹克隆加氟西汀与安慰剂加氟西汀的疗效,明确证明了改善失眠症状对抑郁结局有附加益处。此外,在该患者群体中,镇静或非镇静药物治疗失眠的疗效是否存在差异尚不清楚。需要进一步开展足够大样本量和足够长随访时间的研究,以评估共病性失眠和抑郁的药物(镇静或非镇静)和心理干预的联合应用。本文综述了该研讨会产生的证据水平、建议以及特别值得进一步研究和讨论的领域。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验